Detalhe da pesquisa
1.
Response to first line platinum-based chemotherapy in mismatch repair deficient (MMRd)/ microsatellite instability high (MSI-high) endometrial carcinoma.
Gynecol Oncol
; 169: 78-84, 2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36521352
2.
Biology and Management of High-Grade Chondrosarcoma: An Update on Targets and Treatment Options.
Int J Mol Sci
; 24(2)2023 Jan 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-36674874
3.
Determinants of the access to remote specialised services provided by national sarcoma reference centres.
BMC Cancer
; 21(1): 631, 2021 May 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-34049529
4.
Pazopanib pharmacokinetically guided dose optimization in three cancer patients with gastrointestinal resection.
Cancer Chemother Pharmacol
; 93(2): 169-175, 2024 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-37620675
5.
A de novo germline pathogenic BRCA1 variant identified following an osteosarcoma pangenomic molecular analysis.
Fam Cancer
; 2024 May 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-38763984
6.
Improving olaparib exposure to optimize adverse effects management.
Ther Adv Med Oncol
; 16: 17588359241248328, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38665845
7.
Relation between Plasma Trough Concentration of Pazopanib and Progression-Free Survival in Metastatic Soft Tissue Sarcoma Patients.
Pharmaceutics
; 14(6)2022 Jun 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-35745797
8.
Association of Energy Expenditure and Efficacy in Metastatic Renal Cell Carcinoma Patients Treated with Nivolumab.
Cancers (Basel)
; 14(13)2022 Jun 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-35804986
9.
Association between Olaparib Exposure and Early Toxicity in BRCA-Mutated Ovarian Cancer Patients: Results from a Retrospective Multicenter Study.
Pharmaceuticals (Basel)
; 14(8)2021 Aug 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-34451901
10.
Impact of the COVID-19 pandemic on the management of cancer patients: the experience of the cancer outpatients department of a university hospital in Paris.
Clin Med (Lond)
; 21(5): e552-e555, 2021 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-34341004
11.
Development and validation of a host-dependent, PDL1-independent, biomarker to predict 6-month progression-free survival in metastatic non-small cell lung cancer (mNSCLC) patients treated with anti-PD1 immune checkpoint inhibitors (ICI) in the CERTIM Cohort: The ELY study.
EBioMedicine
; 73: 103630, 2021 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-34688030
12.
Prevalence of drug-drug interactions in sarcoma patients: key role of the pharmacist integration for toxicity risk management.
Cancer Chemother Pharmacol
; 88(4): 741-751, 2021 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-34304283
13.
[Clinical pharmacology and immunotherapy, 4th edition of the congress of pharmacology of anticancer drugs]. / Pharmacologie clinique et immunothérapie, 4e journée de pharmacologie des antitumoraux.
Bull Cancer
; 104(9): 807-811, 2017 Sep.
Artigo
em Francês
| MEDLINE | ID: mdl-28784244